![](/img/cover-not-exists.png)
LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2
Wen, Ji-Feng, Jiang, Yong-Qing, Li, Chao, Dai, Xian-Kui, Wu, Tong, Yin, Wen-ZheVolume:
28
Journal:
Cancer Biomarkers
DOI:
10.3233/CBM-191181
Date:
May, 2020
File:
PDF, 6.03 MB
2020